Tilpisertib Fosmecarbil
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tilpisertib Fosmecarbil, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]